In the event of a takeover/merger, they may give options holders an opportunity to exercise their options during the offer period.
e.g. from the recently announced Genesis and Dacian merger:
"The Offer extends to all Dacian Shares currently on issue, and those issued during the Offer period as a result of the exercise of currently issued options or performance rights. Based on Genesis’ last closing price of $1.205 on 1 July 2022, the implied value of the Offer Consideration is $0.102 per Dacian Share which values Dacian at approximately $111 million (on a fully diluted basis as of the date of this announcement4)."
- Forums
- ASX - By Stock
- Ann: Quarterly Cashflow Report 30 June 2022
In the event of a takeover/merger, they may give options holders...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HRZ (ASX) to my watchlist
|
|||||
Last
3.7¢ |
Change
-0.001(2.63%) |
Mkt cap ! $41.38M |
Open | High | Low | Value | Volume |
3.8¢ | 3.8¢ | 3.7¢ | $3.883K | 102.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 192829 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 192829 | 0.037 |
2 | 29385 | 0.035 |
3 | 94810 | 0.034 |
1 | 140000 | 0.033 |
2 | 1015153 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 9850 | 1 |
0.038 | 70000 | 1 |
0.040 | 79850 | 1 |
0.041 | 156306 | 1 |
0.043 | 200000 | 1 |
Last trade - 15.20pm 11/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
HRZ (ASX) Chart |